About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Ovarian Cancer Clinical Trials | 4,039 Studies Recruiting

Clinical TrialsOvarian Cancer

Ovarian Cancer Clinical Trials

Browse 4,039 clinical trials for ovarian cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1161-1180 of 4,039 trials

CompletedRecombinant Measles Virus Vaccine Therapy and Oncolytic Virus Therapy in Treating Patients With Progressive, Recurrent, or Refractory Ovarian Epithelial Cancer or Primary Peritoneal CancerRATIONALE: A gene-modified virus may be able to kill tumor cells without damaging normal cells.NCT00408590·Rochester, Minnesota TerminatedPhysician-Patient Communication and Expectations Regarding Ovarian Cancer PrognosisThe primary objective is to administer a cross-sectional survey to directly compare the differences patients and physicians hold regarding ovarian cancer prognosis and survival…NCT02769546·Philadelphia, Pennsylvania Not yet recruitingMo-Rez in First- Line (1L) Maintenance Treatment of Non-Homologous Recombination Deficient Ovarian Cancer (Non-HRd OC) [BEHOLD-Ovarian03]This study specifically aims to evaluate how well mocertatug rezetecan (Mo-Rez) alone or in combination with bevacizumab works in treating ovarian cancer compared to bevacizumab…NCT07694427 CompletedA Study of DMOT4039A in Participants With Unresectable Pancreatic or Platinum-Resistant Ovarian CancerThis multicenter, open-label, dose-escalating study will assess the safety, tolerability, and pharmacokinetics of DMOT4039A in participants with unresectable pancreatic or…NCT01469793·Phoenix, Arizona and 5 others

Related Searches

ovary cancertrials

Data from ClinicalTrials.govTerms

Not yet recruitingFasting Mimicking Diet (FMD) in Conjunction With Chemotherapy in Advanced Ovarian CancerRates of grade 3-4 toxicity with carboplatin and paclitaxel chemotherapy range 26-84%. Interventions to reduce toxicity are needed.NCT05921149·Evanston, Illinois

RecruitingTwo Therapeutic Strategies in First-line in Patients With Epithelial Advanced Ovarian CancerCHIMOVIP is a study to determine the best therapeutic strategy in patient with ovarian advanced cancer.NCT03025477·Dijon and 6 others

CompletedEnhance the Use of Genetic Counseling and Testing in LatinasThe investigators will conduct a two-arm RCT to evaluate the preliminary effectiveness of a culturally-adapted video developed by the team vs. a FORCE fact sheet on enhancing…NCT04544501·Washington D.C., District of Columbia and 3 others

RecruitingAutologous CAR-T Cells Targeting B7H3 in Ovarian Cancer iC9-CAR.B7-H3 T CellsThe purpose of this study is to test the safety and tolerability of using a new treatment called autologous T lymphocyte chimeric antigen receptor cells against the B7-H3 antigen…NCT06305299·Chapel Hill, North Carolina

CompletedImaging Study on Halcyon 4.0 System for Patients Receiving Radiation TherapyThis prospective imaging study is evaluating the feasibility of using the Halcyon 4.0 radiotherapy system for radiation therapy planning in patients with cancer.NCT05427214·St Louis, Missouri

UnknownSymptom Management in Patients With Recurrent or Persistent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerThis randomized clinical trial is studying two different symptom management programs to see how well they work compared with usual care in patients with recurrent or persistent…NCT00958698·Phoenix, Arizona and 143 others

UnknownEarly Detection of Cancers in Low Resource CountriesThe purpose of this study is to implement a community-based combined program for early detection of breast, cervical, ovarian and endometrial cancer in low-resource countries…NCT01178736·São Paulo and 2 others

CompletedLapatinib and Paclitaxel in Treating Patients With Advanced Solid TumorsRATIONALE: Drugs used in chemotherapy, such as paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing.NCT00313599·San Francisco, California

RecruitingNo-Stoma Policy in Advanced Ovarian Cancer SurgeryResection of the sigmoid-rectum is a procedure frequently required in cytoreductive surgery for advanced ovarian cancer, and it is also among the procedures with the highest risk…NCT07213193·Roma

RecruitingStudy of Carboplatin and Mirvetuximab Soravtansine in First-Line Treatment of Patients Receiving Neoadjuvant Chemotherapy With Advanced-Stage Ovarian, Fallopian Tube or Primary Peritoneal CancerThe proposed study design is a single arm Phase II trial to document the feasibility of carboplatin-mirvetuximab - in patients with advanced-stage EOC.NCT04606914·Birmingham, Alabama and 8 others

CompletedTargeted Disruption to Cancer Metabolism and Growth Through Dietary Macronutrient ModificationThe objective of this investigation is to examine the effects of 12 weeks of usual care plus a ketogenic diet (KD) or usual care plus dietary recommendations endorsed by the…NCT03171506

CompletedFirst-line Intraperitoneal Cisplatin and Etoposide Chemotherapy for Ovarian CancerThe purpose of this study is to evaluate the role of an additional intraperitoneal chemotherapy with cisplatin and etoposide in bulky advanced epithelial ovarian cancer.NCT01669226·Nanjing, Jiangsu and 6 others

CompletedPOEM STUDY: A Phase IIa Trial in Endometrial Carcinoma With TemsirolimusType of Application: Clinical trial of new indication.NCT02093598·Barcelona and 2 others

CompletedVaccine Therapy Plus Interleukin-2 in Treating Women With Stage IV, Recurrent, or Progressive Breast or Ovarian CancerRATIONALE: Vaccines may make the body build an immune response to kill tumor cells. Interleukin-2 may stimulate a person's white blood cells to kill tumor cells.NCT00019916·Bethesda, Maryland and 1 other

CompletedChemosensitivity Testing to Assign Treatment for Patients With Stage III or Stage IV Ovarian CancerRATIONALE: Chemosensitizers may increase the effectiveness of a chemotherapy drug by making tumor cells more sensitive to the drug.NCT00003214·Aarau and 9 others

CompletedA Study of Cediranib and Olaparib at Disease Worsening in Ovarian CancerThis is a proof of concept study (a study to initially assess the benefit a new drug indication) of the combination of two investigational drugs cediranib and olaparib in patients…NCT02681237·Toronto, Ontario

PreviousPage 59 of 202Next